Peroxisome proliferator-activated receptor alpha (PPARα) is a known metabolic regulator of lipid metabolism in the gut and liver and is an attractive therapeutic target for metabolic syndromes and NAFLD (16, 17). Here, PPARA is linked to metabolic syndrome.